Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver
Proton pump inhibitors (PPIs) are one of the most prescribed drugs around the world. PPIs induce microbiota modulation such as obesity both in humans and in animal models. However, since PPIs can induce microbiota modulation despite the absence of a high-fat diet or weight gain, it is an interesting...
Main Authors: | Heloisa B. Assalin, Kelly Cristiane Gabriel De Almeida, Dioze Guadagnini, Andrey Santos, Caio J. Teixeira, Silvana Bordin, Guilherme Z. Rocha, Mario J. A. Saad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/22/13766 |
Similar Items
-
Proton Pump Inhibitors: How Safe is Long Usage of Pantoprazole?
by: Yu.M. Stepanov, et al.
Published: (2013-09-01) -
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
A dual role of proton pump inhibition on cancer: a critical review
by: Edizer Deniz Tuna, et al.
Published: (2023-02-01) -
Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
by: Jeff D. Olivarez, et al.
Published: (2023-01-01)